S. Orbach‐Arbouys

800 total citations
75 papers, 653 citations indexed

About

S. Orbach‐Arbouys is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, S. Orbach‐Arbouys has authored 75 papers receiving a total of 653 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Immunology, 21 papers in Oncology and 14 papers in Molecular Biology. Recurrent topics in S. Orbach‐Arbouys's work include Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (9 papers) and HIV Research and Treatment (6 papers). S. Orbach‐Arbouys is often cited by papers focused on Immune Cell Function and Interaction (12 papers), Immunotherapy and Immune Responses (9 papers) and HIV Research and Treatment (6 papers). S. Orbach‐Arbouys collaborates with scholars based in France, Mexico and Italy. S. Orbach‐Arbouys's co-authors include M. Geffard, Alejandro Bravo‐Cuéllar, M F Poupon, G Mathé, Richard K. Gershon, Laurence Bonhomme‐Faivre, M Castés, J.F. Petit, K. Kosmatopoulos and Adrián Daneri‐Navarro and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and JNCI Journal of the National Cancer Institute.

In The Last Decade

S. Orbach‐Arbouys

69 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Orbach‐Arbouys France 14 224 146 139 85 65 75 653
Mark K. Haynes United States 13 140 0.6× 199 1.4× 83 0.6× 41 0.5× 62 1.0× 28 621
R. N. Taub United States 15 218 1.0× 235 1.6× 206 1.5× 111 1.3× 41 0.6× 35 819
Leslie Obert United States 15 123 0.5× 121 0.8× 165 1.2× 216 2.5× 53 0.8× 29 770
Munehisa Takahashi Japan 14 433 1.9× 258 1.8× 145 1.0× 89 1.0× 94 1.4× 19 813
Shingi Nakae Japan 6 292 1.3× 304 2.1× 91 0.7× 134 1.6× 66 1.0× 13 795
Ann Mander United Kingdom 15 383 1.7× 320 2.2× 230 1.7× 103 1.2× 44 0.7× 24 966
Aline Sandouk United States 9 576 2.6× 360 2.5× 118 0.8× 258 3.0× 59 0.9× 14 1.2k
Viraga Haridas United States 14 354 1.6× 338 2.3× 103 0.7× 222 2.6× 165 2.5× 22 941
Chrysothemis C. Brown United States 13 648 2.9× 373 2.6× 149 1.1× 50 0.6× 50 0.8× 28 1.1k
A K Duwe Canada 12 505 2.3× 209 1.4× 120 0.9× 87 1.0× 45 0.7× 16 1.0k

Countries citing papers authored by S. Orbach‐Arbouys

Since Specialization
Citations

This map shows the geographic impact of S. Orbach‐Arbouys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Orbach‐Arbouys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Orbach‐Arbouys more than expected).

Fields of papers citing papers by S. Orbach‐Arbouys

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Orbach‐Arbouys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Orbach‐Arbouys. The network helps show where S. Orbach‐Arbouys may publish in the future.

Co-authorship network of co-authors of S. Orbach‐Arbouys

This figure shows the co-authorship network connecting the top 25 collaborators of S. Orbach‐Arbouys. A scholar is included among the top collaborators of S. Orbach‐Arbouys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Orbach‐Arbouys. S. Orbach‐Arbouys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hernández‐Flores, Georgina, Jorge Ramiro Domínguez-Rodríguez, José Manuel Lerma-Díaz, et al.. (2006). Gamma-irradiation induced apoptosis in peritoneal macrophages by oxidative stress. Implications of antioxidants in caspase mitochondrial pathway.. PubMed. 25(6B). 4091–100. 10 indexed citations
2.
Montoya-Fuentes, Héctor, et al.. (2003). Identification of DNA sequences and viral proteins of 6 human papillomavirus types in retinoblastoma tissue.. PubMed. 23(3C). 2853–62. 27 indexed citations
3.
Vásquez‐Garibay, Edgar M., et al.. (2000). The Amikacin on premature newborn: schema of treatment defined by gestational and postnatal age.. 11(4). 251–256. 1 indexed citations
4.
Bonhomme‐Faivre, Laurence, et al.. (1999). Formulation of a Charcoal Suspension for Intratumoral Injection. Study of Galenical Excipients. Drug Development and Industrial Pharmacy. 25(2). 175–186. 4 indexed citations
5.
Mathé, G, E. Chenu, C Bourut, & S. Orbach‐Arbouys. (1993). The in vivo effect of ellipticine analogues on the blood concentration of Friend virus: a murine model for studying anti-HIV drugs. Biomedicine & Pharmacotherapy. 47(10). 457–460. 9 indexed citations
6.
Orbach‐Arbouys, S., et al.. (1993). Macrophage activity may be modified in vivo by galenical excipients. International Journal of Pharmaceutics. 96(1-3). R7–R10. 1 indexed citations
7.
Bravo‐Cuéllar, Alejandro, et al.. (1992). The bactericidal capacity of peripheral blood monocytes from HIV positive patients may collapse very soon after the infection. Immunology Letters. 31(3). 297–299. 11 indexed citations
8.
Mathé, G, et al.. (1992). Retrospective study correlating clinical infectious history and peripheral blood T-cell subpopulations in cancer, GvH and HIV+ patients. Biomedicine & Pharmacotherapy. 46(1). 17–19. 2 indexed citations
9.
Bravo‐Cuéllar, Alejandro, et al.. (1990). Enhanced production of interleukin 1 by mouse peritoneal macrophages after aclacinomycin administration. Immunology Letters. 23(3). 165–172. 5 indexed citations
10.
Balercia, Giancarlo, et al.. (1990). Allo‐activated CD4+ and CD8+ lymphocyte subsets: New ultrastructural findings based on computer‐assisted image analysis. European Journal Of Haematology. 44(3). 179–185. 2 indexed citations
11.
Bravo‐Cuéllar, Alejandro, et al.. (1989). Enhanced activity of peritoneal cells after aclacinomycin injection: effect of pretreatment with superoxide dismutase on aclacinomycin-induced cytological alterations and antitumoral activity.. PubMed. 49(6). 1578–86. 9 indexed citations
12.
Bravo‐Cuéllar, Alejandro, et al.. (1989). In vivo immunopharmacological properties of the traditional Chinese medicine Kang Fu-Xin (KFX). 5(1). 25–33. 1 indexed citations
13.
Orbach‐Arbouys, S., et al.. (1987). Specific suppression of the in vitro parent anti-hybrid reaction. Cellular Immunology. 104(2). 320–333. 1 indexed citations
14.
Orbach‐Arbouys, S., et al.. (1986). Enhancement of NK-Cell Activity in Normal and Tumor-Bearing Mice after Administration of Aclacinomycin. Chemotherapy. 32(2). 142–147. 3 indexed citations
15.
Orbach‐Arbouys, S., Jean‐Pierre Tenu, & J.F. Petit. (1983). Enhancement of in vitro and in vivo Antitumor Activity by Cord Factor (6-6′-Dimycolate of Trehalose) Administered Suspended in Saline. International Archives of Allergy and Immunology. 71(1). 67–73. 25 indexed citations
16.
Orbach‐Arbouys, S. & M Castés. (1979). Augmentation of immune responses after methotrexate administration.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(2). 265–9. 13 indexed citations
17.
Mathé, G, I. Florentin, M. Bruley-Rosset, et al.. (1978). Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy.. PubMed. 62(11). 1613–21. 2 indexed citations
18.
Florentin, I. & S. Orbach‐Arbouys. (1977). [Spleen reactivity after BCG treatement: test and strain dependency of the response].. Library Stack (Library Stack). 128(1-2). 271–2. 3 indexed citations
19.
Orbach‐Arbouys, S., et al.. (1976). Cell interactions in the suppression of in vitro antibody responses.. The Journal of Experimental Medicine. 143(6). 1421–1428. 25 indexed citations
20.
Geffard, M. & S. Orbach‐Arbouys. (1976). Enhancement of T suppressor activity in mice by high doses of BCG. Cancer Immunology Immunotherapy. 1-1(1-2). 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark K. Haynes Breakdown of academic impact, for papers by R. N. Taub Breakdown of academic impact, for papers by Leslie Obert Breakdown of academic impact, for papers by Munehisa Takahashi Breakdown of academic impact, for papers by Shingi Nakae Breakdown of academic impact, for papers by Ann Mander Breakdown of academic impact, for papers by Aline Sandouk Breakdown of academic impact, for papers by Viraga Haridas Breakdown of academic impact, for papers by Chrysothemis C. Brown Breakdown of academic impact, for papers by A K Duwe
Rankless by CCL
2026